Estimation of risk and interaction of single nucleotide polymorphisms at angiotensinogen locus causing susceptibility to essential hypertension: a case control study
Restricted accessResearch articleFirst published online December, 2012
Estimation of risk and interaction of single nucleotide polymorphisms at angiotensinogen locus causing susceptibility to essential hypertension: a case control study
The risk conferred by the variants and haplotypes of single nucleotide polymorphisms (SNPs) at human angiotensinogen (AGT) gene to essential hypertension (EHT) have been described in several populations with variations in the results attributed to their ethnicity. We attempted to evaluate the risk of -217G>A, -152G>A, -20A>C, -6G>A, T174M, M235T and 15241A>G polymorphisms at AGT locus along with the analyses of haplotype and epistatic interactions in causing susceptibility to EHT.
Method:
Two-hundred and forty-nine hypertensives and 248 controls were genotyped for the selected markers.
Results:
Study of demographic parameters revealed significant association of obesity, positive family history and non-vegetarian diet habit, suggesting elevated risk of the condition when associated with these parameters. Significantly high risk for males with AA genotype of -217G>A polymorphism was observed for developing EHT (p = .07). Males with -217A (p = .01) showed a two-fold higher risk for EHT. Markers -217G>A and -6G>A were in strong linkage disequilibrium in patients as compared to controls. Strong epistatic interactions were found between -6G>A, M235T and -217G>A markers, supporting the synergistic effect between them leading to EHT.
Conclusion:
Our findings suggest that -217A variant is significantly associated with the risk for EHT in males. Further studies on the functional role of the marker -217 are recommended for understanding the cause of association with EHT.
JeunemaitreXSoubrierFKotelevtsevYV. Molecular basis of human hypertension: Role of angiotensinogen. Cell1992; 71: 169–180.
2.
CaulfieldMLavenderPFarrallM. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med1994; 330: 1629–1633.
3.
CaulfieldMLavenderPNewell-PriceJ. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest1995; 96: 687–692.
4.
AtwoodLDKammererCMSamollowPB. Linkage of essential hypertension to the angiotensinogen locus in Mexican Americans. Hypertension1997; 30: 326.
5.
NiuTXuXRogusJ. Angiotensinogen gene and hypertension in Chinese. J Clin Invest1998; 101: 188–194.
6.
BrandEChatelainNKeavneyB. Evaluation of the angiotensinogen locus in human essential hypertension—A European study. Hypertension1998; 31: 725–729.
7.
IsaMNBoydEMorrisonN. Assignment of the human angiotensinogen gene to chromosome 1q42-q43 by nonisotopic in situ hybridization. Genomics1990; 8: 598–600.
8.
Gaillard-SanchezIMatteiMGClauserE. Assignment by in situ hybridization of the angiotensinogen gene to chromosome band 1q4, the same region as the human renin gene. Hum Genet1990; 84: 341–343.
9.
JeunemaitreXInoueIWilliamsC. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet1997; 60: 1448–1460.
10.
Rodríguez-PérezJCRodríguez-EsparragónFHernández-PereraO. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: The procagene study. J Am Coll Cardiol2001; 37: 1536–1542.
11.
PereiraACMotaGFACunhaRS. Angiotensinogen 235T allele “dosage” is associated with blood pressure phenotypes. Hypertension2003; 41: 25.
12.
LiNFZhouLWuWD. The relationship between the variants in 5′ upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang. Zhonghua Yi Xue Yi Chuan Xue Za Zhi2004; 21: 23–28.
13.
Van den BornBJVanMontfransGAUitterlindenAG. The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients. J Hypertens2007; 25: 2227–2233.
14.
PereiraTVNunesACFRudnickiM. Meta-analysis of the association of 4 angiotensinogen polymorphisms with essential hypertension. A role beyond M235T?Hypertension2008; 51: 778.
15.
FangYJDengHBThomasGN. Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese. J Hypertens2010; 28: 1203–1209.
16.
JiLDZhangLNShenP. Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population: A meta-analysis. J Hypertens2010; 28: 419–428.
17.
RotimiCMorrisonLCooperR. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension1994; 24: 591–594.
18.
FornageMTurnerSTSingCF. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: A population-based case-control study from Rochester, Minnesota. Hum Genet1995; 96: 295–300.
19.
NiuTChenCYangJ. Blood pressure and the T174M and M235T polymorphisms of the angiotensinogen gene. Ann Epidemiol1999; 9: 245–253.
20.
KatoNSugiyamaTMoritaH. Angiotensinogen gene and essential hypertension in the Japanese: Extensive association study and meta-analysis on six reported studies. J Hypertens1999; 17: 757–763.
21.
KatoNSugiyamaTMoritaH. Comprehensive analysis of the renin-angiotensin gene polymorphisms with relation to hypertension in the Japanese. J Hypertens2000; 18: 1025–1031.
22.
ProvinceMABoerwinkleEChakravartiA. Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program. JHypertens. 2000; 18: 867–876.
23.
KishimotoTSuyamaAIgarashiA. Angiotensinogen gene variation and hypertension in a cohort study in Japanese. J Epidemiol2001; 11: 115–119.
24.
WangJHLinCMWangLS. Association between molecular variants of the angiotensinogen gene and hypertension in Amis tribes of eastern Taiwan. J Formos Med Assoc. 2002; 101: 183–188.
25.
WuXLukeARiederM. An association study of angiotensinogen polymorphisms with serum level and hypertension in an African-American population. J Hypertension2003; 21: 1847–1852.
26.
NiuWQiYCenW. Genetic polymorphisms of angiotensinogen and essential hypertension in a Tibetan population. Hypertension Res2007; 30: 1129–1137.
27.
GhazaliDMRehmanARahmanAR. Candidate gene polymorphisms and their association with hypertension in Malays. Clinica Chimica Acta2008; 388: 46–50.
28.
BasakAASipahiTUstundagS. Association of angiotensinogen T174M and M235T gene variants with development of hypertension in Turkish subjects of Trakya region. Biotechnology and Biotechnology Equipment2008: 22; 984–989.
29.
YuanJTangWChunY. Angiotensinogen T174M and M235T variants and hypertension in the Hani and Yi minority groups of China. Biochem Genet2009; 47: 344–350.
30.
FasolaAFMartzBLHelmerOM. Plasma renin activity during supine exercise in offspring of hypertensive patients. J Appl Physiol. 1968; 25: 410–415.
31.
WalkerWGWheltonPKSaitoH. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension1978; 1: 287–291.
32.
GouldABGreenD. Kinetics of human renin and human substrate reaction. Cardiovasc Res1971; 5: 86–89.
33.
GardesJBouhnikJClauserE. Role of angiotensinogen in blood pressure homeostasis. Hypertension1982; 4: 185–189.
34.
MenardJEl-AmraniAIKSavoieF. Angiotensinogen: Attractive and underrated participants in hypertension and inflammation. Hypertension1991; 18: 705–706.
35.
ForresterTMcFarlane-AndersonNBennetF. Angiotensinogen and blood pressure among blacks: Findings from a community survey in Jamaica. J Hypertens1996; 14: 315–321.
36.
LahiriDKNurnbergerJIJr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res1991; 19: 5444.
37.
XiaoFWeiHSongS. Polymorphisms in the promoter region of the angiotensinogen gene are associated with liver cirrhosis in patients with chronic hepatitis B. J GastroenterolHepatol2006; 21: 1488–1491.
38.
SatoNKatsuyaTNakagawaT. Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. Life Sci2000; 68: 259–272.
39.
ProcopciucLPopescuTJebeleanuG. Essential arterial hypertension and polymorphism of angiotensiongen M235T gene. J Cell Mol Med. 2002; 6: 245–250.
40.
RitchieMDHahnLWRoodiN. Multifactor-dimensionality reduction reveals high-order interactions among estrogen metabolism genes in sporadic breast cancer. Am J Hum Genet2001; 69: 138–147.
41.
MooreJHWilliamsSM. New strategies for identifying gene-gene interactions in hypertension. Ann Med2002; 34: 88–95.
42.
HahnLWRitchieMDMooreJH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics2003, 19: 376–382.
43.
MooreJHGilbertJCTsaiCT. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol2006; 241: 252–261.
44.
IshigamiTUmemuraSTamuraK. Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension1997; 30: 1325–1330.
45.
RahmouniKCorreiaMLG WG. Obesity-associated hypertension:New insights into mechanisms. Hypertension2005; 45: 9.
46.
NarkiewiczK. Obesity and hypertension—the issue is more complex than we thought. Nephrol Dial Transplant2006; 21: 264–267.
47.
YanaiKNibuYMurakamiK. A cis-acting DNA located between TATA box and transcription initiation site is critical in response to regulatory sequence in human angiotensinogen gene. J Biol Chem1996; 271: 15981–15986.
48.
InoueINakajimaTWilliamsCS. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest1997; 7: 1786–1797.
49.
JainSTangXNarayananCS. Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans. JBiol Chem2002; 277: 36889–36896.
50.
WuSJChiangFTJiangJR. The G-217A variant of the angiotensinogen gene affects basal transcription and is associated with hypertension in a Taiwanese population. J Hypertens2003; 21: 2061–2067.
51.
RobinsonMWilliamsSM. Role of two angiotensinogen polymorphisms in blood pressure variation. J Hum Hypertens2004; 12: 865–869.
52.
SayYHLingKHDuraisamyG. Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: A case control study. BMC CardiovascDisord2005; 5: 7.
53.
NairKGShaliaKKAshavaidTF. Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. J Clin Lab Anal2003; 17: 141–146.
54.
KarthikeyanMRoseRShrideviV. Core promoter variants (A-20C, T-18C and G-6A) of the angiotensinogen (AGT) gene are not significantly associated with hypertension in patients of Tamilnadu, India. Int J Hum Genet2009; 9: 13–19.
55.
TiagoADSamaniNJCandyGP. Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation2002; 106: 1483.
56.
ChavesFJGinerVCorellaD. Body weight changes and the A-6G polymorphism of the angiotensinogen gene. Int J Obes Relat Metab Disord2002; 26: 1173–1178.
57.
BennettCLSchraderAPMorrisBJ. Cross-sectional analysis of Met235–>Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun1993; 197: 833–839.
58.
NiuWQiYHouS. Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: The Fangshan study. J Hypertens2009; 27: 1384–1391.
59.
HataANamikawaCSasakiM. Angiotensinogen as a risk factor for hypertension in Japan. J Clin Invest1994; 93: 1285–1287.
60.
IwaiNOhmichiNNakamuraY. Molecular variants of the angiotensinogen as a risk factor for essential hypertension in Japanese populations. Hypertens Res1994; 17: 117–121.
61.
KamitaniARakugiHHigakiJ. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens1994; 8: 521–524.
62.
NishiumaSKarioKKayabaK. Effect of the angiotensinogen gene Met235–>Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens1995; 13: 717–722.
63.
IwaiNShimoikeHOhmichiN. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension1995; 25: 688–693.
64.
ChiangFTHsuKLTsengCD. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens1997; 15: 607–611.
65.
OrtleppJRMetrikatJMevissenV. Relation between angiotensionogen (AGT) M235T gene polymorphism and blood pressure in a large homogeneous study population. J Hum Hypertens2003; 17: 555–559.
66.
JainSLiYPatilS. A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity. J Mol Med2005; 83: 121–131.
67.
WuSJChiangFTChenWJ. Three single nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: Single locus genotype vs. haplotype analysis. Physiol Genomics2004; 17: 79–86.
68.
WilliamsSMAddyJHPhillipsJAIII. Combination of variants in multiple genes are associated with hypertension. Hypertension2000; 36: 2–6.
69.
TsaiCTFallinDChiangFT. Angiotensinogen gene haplotype and hypertension: Interaction with ACE gene I allele. Hypertension2003; 41: 9–15.
70.
WangWYGlennCLZhangW. Exclusion of angiotensinogen gene in molecular basis of human hypertension: Sibpair linkage and association analysis in Australian Anglo-Caucasians. Am J Med Genet1999; 87: 53–60.
71.
IshigamiTTamuraKFujitaT. Angiotensinogen gene polymorphism near transcription start site and blood pressure: Role of a T-to-C transition at intron I. Hypertension1999; 34: 430–434.
72.
ZhuXChangYPCYanD. Association between hypertension and genes in the renin-angiotensin system. Hypertension2003; 41: 1027–1034.
73.
ZhuXYanDCooperRS. Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: Findings from the family blood pressure program. Genome Res2003; 13: 173–181.
74.
NejatizadehAKumarRStobdanT. Significance of angiotensinogen gene haplotypes and genotypes combinations in hypertension. J Hypertens2008; 26: 1094–1101.
75.
BrandERingelJSharmaAM. Role of the angiotensinogen gene for essential hypertension. Herz2000; 25: 15–25.
76.
LiYJainSPatilS. A haplotype of angiotensinogen gene that is associated with essential hypertension increases its promoter activity in adipocytes. Vascul Pharmacol2006; 44: 29–33.
77.
KumarALiYPatilS. A haplotype of the angiotensinogen gene is associated with hypertension in African Americans. Clin Exp Pharmacol Physiol2005; 32: 495–502.
